110
Participants
Start Date
May 11, 2023
Primary Completion Date
January 17, 2025
Study Completion Date
October 31, 2025
Ripasudil
K-321 ophthalmic solution
Placebo
Placebo ophthalmic solution
Dr. Greg Moloney, Vancouver
Rigshospitalet Glostrup-Valdemar Hansens Vej 1-23, Glostrup Municipality
Aarhus Universitetshospital, Aarhus N
NYU Langone Health, New York
Hospital Arruzafa, Córdoba
Althaia Xarxa Assistencial Universitaria Manresa, Manresa
Instituto Oftalmologico Fernandez Vega, Oviedo
Bascom Palmer Eye Institute, Palm Beach Gardens
Gorovoy MD Eye Specialists, Fort Myers
Universitatsklinikum Dusseldorf, Düsseldorf
University of Kentucky, Lexington
University Hospitals Cleveland Medical Center - 11100 Euclid Ave, Cleveland
Cincinnati Eye Institute-1945 Cei Dr, Blue Ash
W Kellogg Eye Center, Ann Arbor
Verdier Eye Center, Grand Rapids
Uniklinik Köln, Cologne
University of Wisconsin School of Medicine and Public Health, Madison
Vance Thompson Vision West Fargo, West Fargo
Universität des Saarlandes, Homburg
Grene Vision Group-Wichita, Wichita
Vance Thompson Vision - Omaha, Omaha
Universitätsklinikum Tübingen, Tübingen
University of Texas Southwestern Medical Center, Dallas
Houston Eye Associates, Houston
R and R Eye Research, LLC., San Antonio
LMU Klinikum der Universität, München
Eye Associates of New Mexico - Albuquerque - Northside, Albuquerque
Keck Hospital of USC, Los Angeles
Macy Eye Center, Los Angeles
Universitätsklinikum Heidelberg, Heidelberg
Universitatsklinkum Erlangen-Ulmenweg 18, Erlangen
Byers Eye Institute at Stanford, Palo Alto
Sacramento Eye Consultants, Sacramento
Devers Eye Institute, Portland
Prism Eye Institute - Mississauga-Oakville, Oakville
Precision Cornea Centre, Ottawa
Hospital Universitario Germans Trias i Pujol, Badalona
Oftalvist - Barcelona, Barcelona
Institut Catala de Retina (ICR), Barcelona
Instituto de Microcirugia Ocular, Barcelona
The Royal Liverpool University Hospital, Liverpool
Moorfields Eye Hospital, London
Royal Victoria Infirmary, Newcastle upon Tyne
Lead Sponsor
Kowa Research Institute, Inc.
INDUSTRY